Rational Design of Pegylated Dendrimer Nanostructures for Site Specific Drug Delivery

用于位点特异性药物递送的聚乙二醇化树枝状聚合物纳米结构的合理设计

• 批准号: LP0774970
• 负责人: Prof Chris Porter
• 金额: $ 17.09万
• 依托单位: Monash University
• 依托单位国家: 澳大利亚
• 项目类别: Linkage Projects
• 财政年份: 2007
• 资助国家: 澳大利亚
• 起止时间: 2007-06-14 至 2010-06-30
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/LP0774970
• 关键词: Rational; Design; Pegylated; Dendrimer; Nanostructures

This project will provide technological advances with significant benefits in terms of improved drug treatment, and therefore health outcomes for Australia. The project builds on areas of research strength in Australia (nanotechnology and biotechnology/biomaterials) and will add considerably to the expanding Australian expertise-base in dendrimer technology (in which it is a world leader). The interdisciplinary nature of this project will also result in a unique training program for the researchers included in this grant. Such experience is in great demand, particularly in Australia where the burgeoning start-up discovery industry is critically short of personnel with skills in drug delivery.

该项目将提供技术进步，在改善药物治疗方面带来重大利益，从而为澳大利亚带来健康成果。该项目以澳大利亚的研究实力领域（纳米技术和生物技术/生物材料）为基础，将大大增加澳大利亚在树状聚合物技术（澳大利亚在这方面处于世界领先地位）方面不断扩大的专门知识基础。该项目的跨学科性质也将导致在一个独特的培训计划的研究人员包括在此补助金。这类经验的需求量很大，特别是在澳大利亚，新兴的发现行业严重缺乏具有药物输送技能的人员。